Yuelong Liang
- Molecular Biology top 10%
- Cancer Research top 2%
- Hepatology top 2%
- Oncology top 10%
- Surgery top 10%
- Co-authors
- Xiujun CaiXiao LiangJunjie XuRenan JinHui LinHong YuShunjie XiaYu Pan
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (15 papers)Liver Disease Diagnosis and Treatment (8 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yuelong Liang
55 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 1.2k
- Cancer Research 823
- Hepatology 419
- Oncology 339
- Surgery 338
Countries citing papers authored by Yuelong Liang
This map shows the geographic impact of Yuelong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuelong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuelong Liang more than expected).
Fields of papers citing papers by Yuelong Liang
This network shows the impact of papers produced by Yuelong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuelong Liang. The network helps show where Yuelong Liang may publish in the future.
Co-authorship network of co-authors of Yuelong Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Yuelong Liang. A scholar is included among the top collaborators of Yuelong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuelong Liang. Yuelong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 13 | |
| 3 | 39 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 13 | |
| 7 | CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1breakdown → | 332 |
| 8 | 219 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 61 | |
| 12 | 9 | |
| 13 | 7 | |
| 14 | 208 | |
| 15 | 5 | |
| 16 | 28 | |
| 17 | 6 | |
| 18 | 10 | |
| 19 | 19 | |
| 20 | 43 |
About Yuelong Liang
Yuelong Liang is a scholar working on Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). The work is most often cited by research in Cancer Research (823 citations), Hepatology (419 citations) and Molecular Biology (1.2k citations). Yuelong Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiujun Cai, Xiao Liang, Junjie Xu, Renan Jin, Hui Lin, Hong Yu, Shunjie Xia, Yu Pan, Jiliang Shen and Senjun Zhou. Their work appears in journals such as PLoS ONE, Science Advances and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.